Table of Contents
Biosimulation is the mathematical simulation of complex, large biological processes on a computer. Biosimulation is being adopted at a faster pace, to extract and interpret vital data from experiments during drug discovery and development.
The report analyzes and presents an overview of Biosimulation market worldwide. The report provides global market estimates and projections for Biosimulation in US dollars for the years 2012 through 2017. Supported with 1 market data table, the report highlights the ever increasing permanence of Biosimulation. The report also provides a review of Biosimulation Models, and Biosimulation software. In addition, 36 companies operating in the Dye Sensitized Cells arena worldwide including Accelrys Inc., Entelos Inc., Rhenovia Pharma SAS and others are profiled.
Get Industry Insights. Simply.
Talk to Veronica
+1 718 514 2762
This IDC Vendor Profile is one in a series of IDC studies that examine automated software quality solutions and provides both vendor analysis and customer reference context for technology adoption. This ...
Global Exploration and Production Software Market: Overview The report provides analysis of the Exploration & Production (E&P) Software market for the period 2014–2024, wherein the years from 2016 to ...
WLAN hardware to play a significant role in augmenting the growth prospects in the enterprise WLAN market This study has been done on a global level covering five regions broadly, North America, Europe, ...